These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 24565101)

  • 1. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
    Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
    Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
    Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
    Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
    Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM
    Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling.
    Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y
    Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2.
    Jin Q; Li XJ; Cao PG
    Tohoku J Exp Med; 2016 Feb; 238(2):143-51. PubMed ID: 26843134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.
    Song WH; Feng XJ; Gong SJ; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM
    Cancer Biol Ther; 2015; 16(12):1754-63. PubMed ID: 26467022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
    Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
    Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-595 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting NF-κB signalling pathway.
    Wang H; Jiang F; Liu W; Tian W
    Pathol Res Pract; 2020 Apr; 216(4):152899. PubMed ID: 32107085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
    Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
    Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
    Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
    Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
    Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
    Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
    Wen J; Huang Z; Wei Y; Xue L; Wang Y; Liao J; Liang J; Chen X; Chu L; Zhang B
    Cell Mol Biol Lett; 2022 Sep; 27(1):79. PubMed ID: 36138344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
    Jiang C; Long J; Liu B; Xie X; Kuang M
    Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
    Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
    Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-26b inhibits the tumor growth of human liver cancer through the PI3K/Akt and NF-κB/MMP-9/VEGF pathways.
    Feng Y; Zu LL; Zhang L
    Oncol Rep; 2018 May; 39(5):2288-2296. PubMed ID: 29498407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-345-3p attenuates apoptosis and inflammation caused by oxidized low-density lipoprotein by targeting TRAF6 via TAK1/p38/NF-kB signaling in endothelial cells.
    Wei Q; Tu Y; Zuo L; Zhao J; Chang Z; Zou Y; Qiu J
    Life Sci; 2020 Jan; 241():117142. PubMed ID: 31825793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.